FHTX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Foghorn Therapeutics Inc.

Watchlist Manager

Watchlist

Price: 6.01 USD -2.59% Market Closed

Market Cap: $352.8m

	Foghorn Therapeutics Inc. NASDAQ:FHTX	US
H	Huaneng Power International Inc XMUN:HUP1	CN
S	Saha Pathana Inter-Holding PCL SET:SPI	TH
S	Sensata Technologies Holding PLC F:S94	US
K	Kuehne und Nagel International AG XMUN:KNIA	CH
	National Vision Holdings Inc NASDAQ:EYE	US
	Invitation Homes Inc F:4IV	US
C	China Pacific Insurance Group Co Ltd XMUN:75C	CN
	Elixirr International PLC LSE:ELIX	UK

Profitability Summary

Foghorn Therapeutics Inc.'s profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-266%

Negative 3Y Average Operating Margin

-370%

Operating Margin is Increasing

-578% > -266%

Negative Net Margin

-240%

Negative 3Y Average Net Margin

-326%

Net Margin is Increasing

-528% > -240%

Negative Free Cash Flow Margin

-279%

Negative 3Y Average Free Cash Flow Margin

-380%

Free Cash Flow Margin is Increasing

-525% > -279%

Exceptional ROE

96%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-246%

ROIC is Increasing

-238% > -230%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.